Clozapine is an antipsychotic medicine and a third line treatment for schizophrenia.
In the majority of cases clozapine will be prescribed by a psychiatrist and dispensed by a hospital pharmacy. It can also be supplied by community pharmacists if they have registered as a provider and completed the required training course.
Concerns about a lack of understanding about the side effects of clozapine as well the effect of missing clozapine doses and the impact of smoking cessation while taking clozapine, and how these can manifest in secondary care were raised at the Northern Ireland Medicine Safety Conference and subsequently shared at a Patient Safety Group meeting.
In response the Patient Safety Group have developed a resource to highlight potential issues associated with clozapine.